Your browser doesn't support javascript.
loading
A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027.
Minegishi, Yuji; Yamaguchi, Ou; Sugawara, Shunichi; Kuyama, Shoichi; Watanabe, Satoshi; Usui, Kazuhiro; Mori, Masahide; Hataji, Osamu; Nukiwa, Toshihiro; Morita, Satoshi; Kobayashi, Kunihiko; Gemma, Akihiko.
Afiliación
  • Minegishi Y; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, 113-8603 1-1-5 Sendagi Bunkyo-Ku, Tokyo, Japan. yminegis@nms.ac.jp.
  • Yamaguchi O; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397 Yamane, Hidaka City, Saitama, 350-1298, Japan.
  • Sugawara S; Department of Pulmonary Medicine, Sendai Kousei Hospital, 4-15 Hirose-machi, Aoba-ku, Sendai, 980-0873, Japan.
  • Kuyama S; Department of Respiratory Medicine, National Hospital Organization, Iwakuni Clinical Center, 1-1-1 Atago Cyo, Iwakuni City, Yamaguchi Prefecture, 740-8510, Japan.
  • Watanabe S; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachidori, Chuouku, Niigata, 951-8510, Japan.
  • Usui K; Division of Respirology, NTT Medical Center Tokyo, 5-9-22 Higashigotanda Shinagawa, Tokyo, Japan.
  • Mori M; Department of Thoracic Oncology, National Hospital Organization Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka City, Osaka, 560-8552, Japan.
  • Hataji O; Respiratory Center, Matsusaka Municipal Hospital, 1550 Tonomachi, Matsusaka City, Mie, 515-8544, Japan.
  • Nukiwa T; Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.
  • Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Kobayashi K; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397 Yamane, Hidaka City, Saitama, 350-1298, Japan.
  • Gemma A; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, 113-8603 1-1-5 Sendagi Bunkyo-Ku, Tokyo, Japan.
BMC Cancer ; 21(1): 208, 2021 Mar 01.
Article en En | MEDLINE | ID: mdl-33648453
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Proteínas Quinasas / Afatinib / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline Límite: Aged / Aged80 / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Proteínas Quinasas / Afatinib / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline Límite: Aged / Aged80 / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Japón